Welcome remarks from Vineet Jain, CEO, Egnyte, followed by Alok Tayi, PhD, VP of Life Sciences at Egnyte as they kick off the Life Sciences Summit and chat with biotech visionaries about the challenges and opportunities in the industry.
Vineet is the CEO and co-founder of Egnyte. Prior to Egnyte, Vineet founded and successfully built Valdero, a supply chain software solution provider, funded by KPCB, MDV and Trinity Ventures. He has held a rich variety of senior operational positions at KPMG and Bechtel. He has 20 years of experience in building capital-efficient and nimble organizations. Vineet earned a BS in Engineering from Delhi College of Engineering and received an MBA from Santa Clara University.
IDC anaylst, Nimita Limaye offers an industry perspective on the state of biotech through the lens of their Top 10 Market Trends for 2021 report.
In this session, BA Insight will discuss and demonstrate how their technology provides Google-like search experiences for their customers in Life Sciences.
Egnyte's product team will share some recent innovations and unveil our future vision of data and document management for the life sciences.
A Closer Look at MIT Tech Review's Predictions For AI-Led Drug Development. In this roundtable, Holly Leslie will interview our two guests, will discuss the latest findings from MIT Tech Review and offer perspectives on how AI is reshaping the way drugs are brought to market.
Egnyte Chief Governance Officer, Jeff Sizemore, outlines 3 mission-critical data governance trends that your organization needs to plan for and manage effectively. You’ll also learn how to minimize potential cyber threats that could damage productivity and impact your reputation.
